| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comparison of cardiovascular and pulmonary morbidities and risk factors in breast cancer survivors compared to an age-matched female control group in the Lifelines prospective population cohort
|
Spoor, D.S.
|
|
|
70 |
C |
p. 49-55
|
article
|
| 2 |
Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland –on behalf of the UK national coordinating committee for breast pathology
|
Zaakouk, Mohamed
|
|
|
70 |
C |
p. 82-91
|
article
|
| 3 |
Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life
|
Stewart, Sarah-Jane F.
|
|
|
70 |
C |
p. 32-40
|
article
|
| 4 |
Does age affect outcome with breast cancer?
|
B Jackson, Emily
|
|
|
70 |
C |
p. 25-31
|
article
|
| 5 |
Editorial Board
|
|
|
|
70 |
C |
p. i
|
article
|
| 6 |
Investigating the prognostic value of mammographic breast density and mammographic tumor appearance in women with invasive breast cancer: The Malmö Diet and cancer study
|
Sturesdotter, Li
|
|
|
70 |
C |
p. 8-17
|
article
|
| 7 |
Nodal response to primary systemic therapy predicts prognosis of cN3c breast cancer patients receiving multimodality therapy
|
Li, Shuyan
|
|
|
70 |
C |
p. 92-99
|
article
|
| 8 |
Prognostic factors and clinical outcomes of breast cancer patients with disease progression during neoadjuvant systemic therapy
|
Ling, Yun-xiao
|
|
|
70 |
C |
p. 63-69
|
article
|
| 9 |
Real-world treatment patterns of subsequent therapy after palbociclib in patients with advanced breast cancer in Japan
|
Sawaki, Masataka
|
|
|
70 |
C |
p. 1-7
|
article
|
| 10 |
Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study
|
Thurell, Jacob
|
|
|
70 |
C |
p. 18-24
|
article
|
| 11 |
The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study
|
Caliskan Yildirim, Eda
|
|
|
70 |
C |
p. 56-62
|
article
|
| 12 |
The long-term psychosocial consequences of screen-detected ductal carcinoma in situ and invasive breast cancer
|
Gram, Emma Grundtvig
|
|
|
70 |
C |
p. 41-48
|
article
|
| 13 |
Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial
|
Geurts, V.C.M.
|
|
|
70 |
C |
p. 76-81
|
article
|
| 14 |
10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection
|
Campbell, Ian
|
|
|
70 |
C |
p. 70-75
|
article
|
Journal description